Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,955.00
-25.00 (-0.63%)
At close: Mar 31, 2026
Market Cap43.16B -20.7%
Revenue (ttm)62.51B -14.4%
Net Income6.51B +117.4%
EPSn/a
Shares Out10.91M
PE Ratio6.63
Forward PEn/a
Dividend160.00 (4.02%)
Ex-Dividend DateDec 29, 2025
Volume19,033
Average Volume14,998
Open3,985.00
Previous Close3,980.00
Day's Range3,850.00 - 3,985.00
52-Week Range3,600.00 - 5,170.00
Beta0.29
RSI47.15
Earnings DateMay 14, 2026

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

In 2025, Korean Drug's revenue was 62.51 billion, a decrease of -14.37% compared to the previous year's 73.00 billion. Earnings were 6.51 billion, an increase of 117.42%.

Financial Statements